Impact of COVID-19 public health measures on myelin oligodendrocyte glycoprotein IgG-associated disorders in children
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 56, 103286
Abstract
No abstract availableKeywords
Funding Information
- Canadian Society of Nephrology
- Canadian Institutes of Health Research
- National Institutes of Health
- Ontario Institute for Regenerative Medicine
- National MS Society
- Rare Disease Foundation
- Biogen
This publication has 12 references indexed in Scilit:
- Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibodyJournal of Neuroimmunology, 2020
- E.U. paediatric MOG consortium consensus: Part 1 – Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disordersEuropean Journal of Paediatric Neurology, 2020
- A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infectionMultiple Sclerosis and Related Disorders, 2017
- Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndromeNeurology, 2017
- Postinfectious Anti–Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and MyelitisJournal of Child Neurology, 2017
- Clinical and MRI phenotype of children with MOG antibodiesMultiple Sclerosis Journal, 2015
- Vagus nerve stimulation in drug-resistant epilepsies. Analysis of potential prognostic factors in a cohort of patients with long-term follow-upActa Neurochirurgica, 2012
- Acute Disseminated Encephalomyelitis in Childhood: Epidemiologic, Clinical and Laboratory FeaturesThe Pediatric Infectious Disease Journal, 2004
- Acute Disseminated Encephalomyelitis in ChildrenPediatrics, 2002
- Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in childrenBrain, 2000